• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

stumpjumper's Profile

Avatar:

Membership:

Demo

Person Marks:

7

Total Posts:

340

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

09/27/2012 12:21:45 AM

Personal info

Recent Articles

• Discover the Exciting Return of White Castle's Chicken Rings!
• Discover Affordable Used Kia Options at Auto Simple Deals
• American Tungsten Corp. Engages at Global Commodities Expo
• Strategic Developments at Nano Dimension and Desktop Metal
• Anavex Life Sciences Engages Global Experts on Alzheimer's
• BULGOLD Unveils Financial Performance Insights for 2024
• Dragonfly Energy's Green Commitment: Planting Trees for Earth
• Compass Lexecon Welcomes Faten Sabry as Senior Managing Director
• Axxess and Texas Capital Collaborate for Swift Payment Solutions
• Cynosure and Checketts Form Groundbreaking Sports Venture
• Innovative Partnership for Kenya's Digital Trading Future
• Readen Holding Signs Major MOU to Enter African Gaming Market
• BD Unveils Advanced Hemodynamic Monitoring Solution to Aid Clinicians
• Zevra Therapeutics: Growth, Strategies, and Board Election Insights
• Rona Therapeutics Advances Innovative Hypertension Therapy RN1871
• FDA Gives NS-229 Orphan Drug Status for Rare Autoimmune Disease
• Discover the New Syntex™ Gloves: A Game Changer in Safety
• Understanding America's Digital Hoarding Challenge
• Elixir AI Soars with 10x Growth in the Crypto Landscape
• Exploring KSD Miner: Transforming Cryptocurrency Investments
• AMG Expands Investment Portfolio with Verition Partnership
• Chairman Gabriele Cerrone Expands Stake in AccuStem Sciences
• Immunovant Advances Leadership and Expands Focus on Autoimmunity
• Omni-Lite Industries Sees Record Revenue in Fiscal 2024 Results
• Craig Wheeler Joins Apellis' Board to Enhance Leadership Team
• Amicus Therapeutics: Upcoming First Quarter Financial Call Insights
• Enzo Biochem, Inc. Marks New Milestone with OTCQX Listing
• Immunovant Expands Leadership and Focus on Key Autoimmune Indications
• USA Rare Earth Prepares for Q1 2025 Results and Call
• OTC Markets Group Reports Strong Growth and Market Adjustments
• CECO Environmental Announces Earnings Release and Call Details
• Ascentage Pharma's Innovative Cancer Treatments Gain Recognition
• BioCryst Pharmaceuticals' Q1 2025 Financial Results Announcement
• Northland Power Welcomes New CFO to Drive Financial Growth
• Arvinas Unveils Promising Data for Its Cancer Treatment ARV-393
• Invivyd Secures $30M Loan Facility to Advance Antibody Treatments
• SIMO and MAYA Technologies Launch Groundbreaking AI Solution
• Kraig Biocraft Labs Enhances Spider Silk Production Efforts
• Perpetua Resources: Key Project Selected for US Mineral Independence
• BioStem Technologies CEO to Speak at Major Investment Conference
• Join Bladex for Its Q1 2025 Earnings Call on May 6
• Rockbridge Growth Equity Transitions GSTV to MidOcean Partners
• Acepodia Showcases Advanced Antibody-Drug Conjugate Insights
• CytoSorbents Secures $1.7M for Innovative Growth Initiatives
• Northstar Clean Technologies Advances Construction Video Series
• Aircastle's Upcoming Fourth Quarter Results Announcement
• ICL's Strategic Move to Enhance Agriculture with Lavie Bio
• Understanding Your Rights in the Sana Biotechnology Lawsuit
• Join the Exploration of Innovations That Shape Our Future
• Rona Therapeutics Receives Approval for RN1871 siRNA Treatment